LBA40_PRTARGET: A RANDOMIZED, PHASE II TRIAL COMPARING VINTAFOLIDE VERSUS VINTAFOLIDE PLUS DOCETAXEL, VERSUS DOCETAXEL ALONE IN SECOND-LINE TREATMENT OF FOLATE-RECEPTOR-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS